Comparison of Sedative Effect of Dexmedetomidine and Midazolam for TIVA

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of sedative effects of dexmedetomidine and midazolam using ramsay sedation scores intraoperatively in children undergoing inguinal hernia repair.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Dexmedetomidine and Midazolam for Intra-op Sedation in TIVA in Children Undergoing Inguinal Hernia Repair

NCT05337085

Inguinal Hernia

UNKNOWN PHASE1

Comparing Two Doses of Midazolam With Added Dexmedetomidine for Kids Before Surgery

NCT06979791

Preoperative Anxiety Experienced by the Pediatric Patient Preoperative Anxiety

NOT_YET_RECRUITING PHASE2

Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair

NCT06389318

Inguinal Hernia Repair

COMPLETED NA

Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children

NCT01091818

Sedation

UNKNOWN PHASE3

Comparison of Oral Dexmedetomidine, Ketamine Versus Midazolam for Premedication in Children Undergoing Injuinal Surgeries

NCT06879496

Pediatric Anesthesia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

a randomized controlled trial to compare the sesative effects of dexmedetomidine and midazolam in pediatric population planned for inguinal herna repair under TIVA in sheikh zayed hospital rahim yar khan.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Choosing Better Drug Option for Sedation in Pediatric Population Intraoperatively

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

midazola.

Inj.midazolam

Group Type EXPERIMENTAL

Midazolam

Intervention Type DRUG

Inj.midazolam 5mg/5ml given in stat doses

Dexnedetomidine

inj.dexmedetomidine

Group Type EXPERIMENTAL

Dexmedetomidine injection

Intervention Type DRUG

Inj precedex 200mcg in 1ml given in stat doses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexmedetomidine injection

Inj precedex 200mcg in 1ml given in stat doses

Intervention Type DRUG

Midazolam

Inj.midazolam 5mg/5ml given in stat doses

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Precidex

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA I and II Age 6 to 12 years Any gender

Exclusion Criteria

* ASA III and above Age less than 2 years and above 12 years Congenital heart disease Cardiac arrythmias Congenital abnormalities Respiratory disease Endocrine disorders Mental retardation Organ dysfunction Bleeding disorders Physician or family refusal Previous surgeries Allergy to any drug

Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes